Warenkorb
Ihnen fehlen nur noch CHF89.00 bis zum kostenlosen Versand.
Ihr Warenkorb ist leer.
Shop NowBad Blood: Secrets and Lies in a Silicon Valley Startup
BS12997561
Column filling
| Ordnen nach Preis | Ordnen nach Verfügbarkeit | Ordnen nach Artikelnummer | Ordnen nach Formatieren |
|---|---|---|---|
CHF570
|
Nicht auf Lager
|
BS12997561
|
Formatieren:
|
Beschreibung
NEW YORK TIMES BEST SELLER • NAMED ONE OF THE BEST BOOKS OF THE YEAR BY: NPR, The New York Times Book Review, Time, Wall Street Journal, Washington Post • The McKinsey Business Book of the Year
The full inside story of the breathtaking rise and shocking collapse of Theranos, the one-time multibillion-dollar biotech startup founded by Elizabeth Holmes—now the subject of the HBO documentary The Inventor—by the prize-winning journalist who first broke the story and pursued it to the end.
“The story is even crazier than I expected, and I found myself unable to put it down once I started. This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion.” —Bill Gates
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work.
A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Eigenschaften
Abmessungen
15.49 x 2.74 x 23.37 cm
Auflage
INT
Erscheinungstermin
21. Mai 2018
Formatieren
Taschenbuch
ISBN-10
1524711489
ISBN-13
978-1524711481
Sprache
Englisch
Bewertungen
Keine Bewertungen gefunden
Bitte melden Sie sich an, damit wir Sie über eine Antwort benachrichtigen können